Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses

Kelly D. Moynihan(Ragon Institute of MGH, MIT and Harvard), Cary F. Opel(Massachusetts Institute of Technology), Gregory L. Szeto(Ragon Institute of MGH, MIT and Harvard), Alice Tzeng(Massachusetts Institute of Technology), Eric Zhu(Massachusetts Institute of Technology), J Engreitz(Broad Institute), Christina Williamson(Massachusetts Institute of Technology), Kavya Rakhra(Massachusetts Institute of Technology), Michael H. Zhang(Massachusetts Institute of Technology), Adrienne M. Rothschilds(Massachusetts Institute of Technology), Sudha Kumari(Massachusetts Institute of Technology), Ryan L. Kelly(Massachusetts Institute of Technology), Byron H. Kwan(Massachusetts Institute of Technology), Wuhbet Abraham(Massachusetts Institute of Technology), Kevin Hu(Massachusetts Institute of Technology), Naveen K. Mehta(Massachusetts Institute of Technology), Monique J. Kauke(Massachusetts Institute of Technology), Heikyung Suh(Massachusetts Institute of Technology), Jennifer R. Cochran(Cancer Prevention Institute of California), Douglas A. Lauffenburger(Ragon Institute of MGH, MIT and Harvard), K. Dane Wittrup(Massachusetts Institute of Technology), Darrell J. Irvine(Howard Hughes Medical Institute)
Nature Medicine
October 24, 2016
Cited by 537Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis